การตรวจตราด้านชีวสมมูล และการเขียน Corrective and Preventive Action (CAPA) (ตอนที่ 1)

International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use. ICH harmonised guideline: integrated addendum to ICH E6(R1): guideline for good clinical practice E6(R2) [Internet]. 2016 [cited 2025 May 18]. Available from: https://www.ich.org/fileadmin/Public_Web_Site/ICH_Products/Guidelines/Efficacy/E6/E6_R2__Addendum_Step4.pdf

U. S. Food and Drug Administration. Abbreviated New Drug Application (ANDA): Generics [Internet]. [cited 2025 May 18]. Available from: https://www.fda.gov/drugs/abbreviated-new-drug-application-anda/abbreviated-new-drug-application-anda-generics.

European Medicines Agency. Guideline on the investigation of bioequivalence [Internet]. 2010 [cited 2025 May 18]. Available from: https://www.ema.europa.eu/en/documents/scientific-guideline/guideline-investigation-bioequivalence_en.pdf

World Health Organization (WHO). Guidelines on bioequivalence: a concept paper. WHO Technical Report Series, No. 937, Annex 7. 2006.

Organisation for Economic Co-operation and Development. OECD principles on good laboratory practice [Internet]. (OECD Series on principles of good laboratory practice and compliance monitoring, No. 1; ENV/MC/CHEM(98)17) [Internet]. OECD; 1998 [cited 2025 May 18]. Available from: https://www.oecd-ilibrary.org/docserver/9789264078536-en.pdf

Pharmaceutical Inspection Co-operation Scheme (PIC/S). PIC/S Guide to Good Manufacturing Practice for Medicinal Products. PE 009-17. 2023.

U.S. Food and Drug Administration. 21 CFR Part 211. Current Good Manufacturing Practice for Finished Pharmaceuticals [Internet]. [cited 2025 June 10]. Available from: https://www.fda.gov/drugs/pharmaceutical-quality-resources/current-good-manufacturing-practice-cgmp-regulations.

U.S. Food and Drug Administration. Compliance Program Guidance Manual (CPGM) for Bioequivalence Inspections. (Specific CPGM relevant to BE inspections) [Internet]. [cited 2025 Jun 3]. Available from: https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/compliance-program-manual/bioresearch-monitoring-program-bimo-compliance-programs

European Medicines Agency. Guideline on the inspection of bioequivalence studies (EMA/INS/GCP/119932/2017) [Internet]. 2017 [cited June 10, 2025]. Available from: https://www.ema.europa.eu/en/documents/scientific-guideline/guideline-inspection-bioequivalence-studies_en.pdf.

International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use. Quality, safety, efficacy and regulatory guidelines [Internet]. [cited 2025 May 18]. Available from: https://www.ich.org/guidelines/quality-safety-efficacy-and-regulatory-guidelines

United States Pharmacopeia. General chapter <1090> In vitro dissolution and drug release testing. In: the united states pharmacopeia and national formulary, USP 43–NF 38. Rockville (MD): U.S. Pharmacopeial Convention; 2020.

World Health Organization. WHO guideline on bioequivalence: Update 2017. Geneva: World Health Organization; 2017.

European Medicines Agency. Guidance for applicants and marketing authorisation holders of generics, hybrid and biosimilar medicinal products: bioequivalence and bioanalytical aspects. London: European Medicines Agency; 2017.

U.S. Food and Drug Administration. Guidance for Industry: Bioanalytical Method Validation. Rockville (MD): U.S. Department of Health and Human Services, Food and Drug Administration, Center for Drug Evaluation and Research (CDER); 2018.